Save the date! Wednesday 6th November 2024, is when MDxHealth SA (NASDAQ: MDXH) will be sharing its eagerly awaited third quarter financial results. Investors and analysts will be able to gain valuable insights into the company's financial performance as the announcement is scheduled after market close.
Financial experts on Wall Street anticipate that the business is set to announce an estimated $0.27 loss per share for the quarter. Furthermore, the company is expected to disclose a total revenue of $21.4 million for this specific period.
During the same quarter of the previous year, the company's earnings report indicated a per-share loss of $0.04. This noteworthy figure was a direct outcome of the company's total revenue, which reached an impressive $19.35 million during that specific period.
Analysts on Wall Street have shared their predictions regarding the annual performance of the company, estimating a total revenue of $85.57 million. Additionally, they are expecting the company to achieve per share loss of $1.2 for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $-0.42 | -1,300.0% | 22.16 M | +33.1% |
| Q1 2024 | $-0.31 | -520.0% | 19.83 M | +34.9% |
| Q4 2023 | $-0.39 | -254.5% | 19.40 M | +50.5% |
| Q3 2023 | $-0.04 | +20.0% | 19.35 M | +73.5% |
| Q2 2023 | $-0.03 | +57.1% | 16.65 M | +141.1% |
| *Growth on year-over-year basis | ||||
In addition, The firm will review the third quarter financial results on 6th November 2024 at 04:30 PM eastern time, in a conference call with public.
MDxHealth SA (MDXH) shares traded as low as $2.05 and as high as $2.08 on a day volume of 30.50 thousand shares, closed Friday's regular trading session at $2.08, a gain of 2.46 percent.